Cargando…

Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies

Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fein, Daniel G., Zaidi, Ali N., Sulica, Roxana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039478/ https://www.ncbi.nlm.nih.gov/pubmed/27571110 http://dx.doi.org/10.3390/jcm5090075

Ejemplares similares

Advances in the management of pulmonary arterial hypertension
por: Deshwal, Himanshu, et al.
Publicado: (2021)

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center
por: Sulica, Roxana, et al.
Publicado: (2015)

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension
por: Sulica, Roxana, et al.
Publicado: (2019)

COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City
por: Sulica, Roxana, et al.
Publicado: (2021)

Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience
por: Deshwal, Himanshu, et al.
Publicado: (2023)

Pulmonary hypertension due to acute respiratory distress syndrome
por: Ñamendys-Silva, S.A., et al.
Publicado: (2014)

Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
por: Sarah, Beshay, et al.
Publicado: (2021)

Postpartum Respiratory Distress Due to Hypertension-Related Pulmonary Edema
por: Randhawa, Johnny S, et al.
Publicado: (2021)

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013)

Management of Pulmonary Hypertension Due to Chronic Lung Disease
por: Sugarman, Jordan, et al.
Publicado: (2021)

Advanced airway management and respiratory care in decompensated pulmonary hypertension
por: Vahdatpour, Cyrus A., et al.
Publicado: (2021)

Common respiratory conditions of the newborn
por: Gallacher, David J., et al.
Publicado: (2016)

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
por: Rosenzweig, Erika B., et al.
Publicado: (2019)

A review of therapeutic agents for the management of pulmonary arterial hypertension
por: Hahn, Stella S, et al.
Publicado: (2016)

Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management
por: Casali, Lucio, et al.
Publicado: (2013)

Diagnosis and management of pulmonary hypertension related to chronic respiratory disease
por: Krompa, Anastasia, et al.
Publicado: (2022)

Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension
por: Yang, Jenny, et al.
Publicado: (2023)

Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
por: Anderson, James J., et al.
Publicado: (2022)

Common genetic variants in pulmonary arterial hypertension
por: Gu, Sue, et al.
Publicado: (2018)

Therapeutic Strategies in Pulmonary Hypertension
por: Fuso, Leonello, et al.
Publicado: (2011)

Pulmonary hypertension due to left heart disease
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial
por: Moosavi, Seyed Ali Javad, et al.
Publicado: (2013)

Evaluation of Community Pharmacists’ Professional Practice and Management of Patient's Respiratory Conditions
por: Al-Qudah, Raja’a A., et al.
Publicado: (2021)

Innovative strategies for the management of common mental disorders
por: Ali, S
Publicado: (2023)

Common Respiratory Viruses and Pulmonary Mucosal Immunology
por: Huang, David B.
Publicado: (2006)

Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort
por: Lammi, Matthew R., et al.
Publicado: (2018)

Management of Common Cardiac Conditions
Publicado: (1948)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension
por: Al-Azem, M. Ali, et al.
Publicado: (2014)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease
por: Alhabeeb, Waleed, et al.
Publicado: (2014)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia
por: Sakkijha, Husam, et al.
Publicado: (2014)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019)

Screening strategies for pulmonary arterial hypertension
por: Kiely, David G, et al.
Publicado: (2019)

Controversies in pulmonary hypertension due to left heart disease
por: Cheli, Martino, et al.
Publicado: (2015)

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios, Konstantinos, et al.
Publicado: (2016)

The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension
por: Stickel, Simone, et al.
Publicado: (2019)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: Pulmonary hypertension due to left heart disease
Publicado: (2017)

Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension
por: Swinnen, Katleen, et al.
Publicado: (2023)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l1c2lltv98to8tba7uqm461ehi